Condition: Congenital Heart Disease · Sponsor: Henning Bundgaard
Copenhagen Baby Heart Study - Impact (CBHS-I) is an extension to Copenhagen Baby Heart (CBH) which included over 25.000 new-borns in the Copenhagen area between 2016-2018. Based on clinical and subclinical deviations in the examinations in CBH, subgroups of participants will be invited to clinical examinations (echocardiography and electrocardiogram) in early childhood. There will also be a new, targeted inclusion based on certain exposures during pregnancy. The main objectives are to assess the prevalence of congenital and inherited heart disease and, and the development of these during early childhood; examining the association between pre- and postnatal exposure, disease, lifestyle, environmental and genetic factors; continue to establish reference values for echocardiography in Danish neonates and children.
This description comes directly from the study's public registry record.
Henning Bundgaard, MD, DMSc · +4535450512 · henning.bundgaard@regionh.dk
Kasper Iversen, MD, DMSc · +4538686009 · kasper.karmark.iversen@regionh.dk
Always discuss trial participation with your own doctor first.
| Rigshospitalet Copenhagen University Hospital. | Copenhagen Ø, Denmark | Recruiting |
| Herlev and Gentofte Hospital | Herlev, Denmark | Recruiting |
| Hvidovre Hospital | Hvidovre, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05838079